Sruti S Akella1, Viral V Juthani. 1. Department of Ophthalmology and Visual Sciences, Montefiore Medical Center, Bronx, New York, USA.
Abstract
PURPOSE OF REVIEW: To summarize the various extended depth of focus (EDOF) intraocular lenses currently available to patients and to describe visual outcomes and patient satisfaction. RECENT FINDINGS: EDOF lenses are a relatively new option for presbyopic correction. Preliminary studies show high levels of spectacle independence and patient satisfaction. The only United States Federal Drug Administration-approved intraocular lens currently on market is the TECNIS Symfony (Johnson and Johnson Vision, Jacksonville, FL). SUMMARY: Early studies show that EDOF lenses may provide satisfactory near and intermediate vision with reduced incidence of haloes and glares often noted by patients implanted with multifocal lenses. Results are promising, but limited.
PURPOSE OF REVIEW: To summarize the various extended depth of focus (EDOF) intraocular lenses currently available to patients and to describe visual outcomes and patient satisfaction. RECENT FINDINGS: EDOF lenses are a relatively new option for presbyopic correction. Preliminary studies show high levels of spectacle independence and patient satisfaction. The only United States Federal Drug Administration-approved intraocular lens currently on market is the TECNIS Symfony (Johnson and Johnson Vision, Jacksonville, FL). SUMMARY: Early studies show that EDOF lenses may provide satisfactory near and intermediate vision with reduced incidence of haloes and glares often noted by patients implanted with multifocal lenses. Results are promising, but limited.
Authors: Francisco de Asís Bartol-Puyal; Galadriel Giménez; Silvia Méndez-Martínez; Irene Altemir; José Manuel Larrosa; Vicente Polo; Luis Pablo Journal: Int Ophthalmol Date: 2021-05-25 Impact factor: 2.031
Authors: Krzysztof Petelczyc; Andrzej Kolodziejczyk; Narcyz Błocki; Anna Byszewska; Zbigniew Jaroszewicz; Karol Kakarenko; Katarzyna Kołacz; Michał Miler; Alejandro Mira-Agudelo; Walter Torres-Sepúlveda; Marek Rękas Journal: Biomed Opt Express Date: 2019-12-04 Impact factor: 3.732
Authors: André Lins de Medeiros; Flavio Jones Saraiva; Camila Ishii Iguma; Danilo Varela Kniggendorf; Guilherme Alves; Mario Augusto Pereira Dias Chaves; Cesar Vilar; Antonio Francisco Pimenta Motta; Pedro Carlos Carricondo; Celso Takashi Nakano; Walton Nosé; Wilson Takashi Hida Journal: Clin Ophthalmol Date: 2019-08-29